The TGA have advised that they have observed an ongoing increase in non-compliant advertising within the complementary medicines sector, particularly for dietary supplements promoted via online and social media channels. This includes advertising that may mislead consumers about product safety, efficacy, or regulatory status.

The Targeted Compliance Unit (TCU) within the TGA will soon initiate a targeted letter campaign focused on addressing non-compliant advertising of dietary supplements, including goods being advertised for a therapeutic purpose, that are not listed on the ARTG. Each identified entity will receive:

• Guidance letter: Outlining requirements for compliance with advertising regulations, including references to relevant legislation, best practice, and guidance. The letter is intended to encourage voluntary review and removal of non-compliant material.
• Fact sheet: Providing practical information on how to meet common advertising requirements.

Recipients will be given four weeks to review and amend their advertising. At the end of this period, the TGA will assess the materials to determine whether adequate corrective action has been taken.

This campaign covers a broad range of advertising, including but not limited to websites, social media posts, testimonials, influencer or affiliate marketing, endorsements, email marketing and other digital content, whether published directly by sponsors or through third parties.

Those who engage in repeated or deliberate serious misconduct will be assessed for potential compliance or enforcement action.

TGA have provided Tips for Complying with TGA Advertising Rules

We strongly recommend that sponsors review their advertising to ensure compliance.

Further guidance is available at:

Understanding listed and registered complementary medicine regulation
Regulation essentials
What can and cannot be advertised to the general public
Understanding activities that represent advertising
Advertising mushroom products that are therapeutic goods
Know how food and medicine are regulated